GBM cells secrete receptor activator of nuclear factor kappa beta (RANKL) which activates the nuclear factor kappa-light-chain-enhancer of the activated B cells (NF-κB) signalling pathway through binding to NF-κB receptors heavily expressed in peripheral GBM tumours. Here, TNFSF11 is linked to glioblastoma.